Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Molecules (Basel, Switzerland)|January 3, 2017
Hydrogen Sulfide in the Adipose Tissue-Physiology, Pathology and a Target for PharmacotherapyJerzy Bełtowski, Anna Jamroz-WiśniewskaCurrent Pharmaceutical Design|May 22, 2013
Transactivation of ErbB receptors by leptin in the cardiovascular system: mechanisms, consequences and target for therapyJerzy Bełtowski, Anna Jazmroz-WiśniewskaAntioxidants & Redox Signaling|November 1, 2011
Modulation of h(2)s metabolism by statins: a new aspect of cardiovascular pharmacologyJerzy Bełtowski, Anna Jamroz-WiśniewskaMolecules (Basel, Switzerland)|December 19, 2014
Hydrogen sulfide and endothelium-dependent vasorelaxationJerzy Bełtowski, Anna Jamroz-WiśniewskaBiochemical Pharmacology|December 17, 2022
Hydrogen sulfide in the experimental models of arterial hypertensionJerzy Bełtowski, Jolanta Kowalczyk-BołtućPrzeglad Lekarski|March 9, 2006
[Some markers of oxidative stress in hypertension induced by chronic inhibition of nitric oxide synthase]Grazyna Wójcicka, Anna Jamroz, Jerzy BełtowskiPPAR Research|April 12, 2013
Thiazolidinedione-induced fluid retention: recent insights into the molecular mechanismsJerzy Bełtowski, Jolanta Rachańczyk, Mirosław WłodarczykObesity Research|December 25, 2003
Stimulatory effect of leptin on nitric oxide production is impaired in dietary-induced obesityJerzy Bełtowski, Grazyna Wójcicka, Anna JamrozJournal of Cardiovascular Pharmacology|December 12, 2003
Effect of 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors (statins) on tissue paraoxonase 1 and plasma platelet activating factor acetylhydrolase activitiesJerzy Bełtowski, Grazyna Wójcicka, Anna JamrozPostepy Higieny I Medycyny Doswiadczalnej|July 18, 2003
[Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy]Jerzy Bełtowski, Grazyna Wójcicka, Anna JamrozPageof 8